Skip to main navigation Skip to search Skip to main content

PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to coMmercial TAVR devices

Project: Research

Project Details

StatusActive
Effective start/end date07/14/2612/1/35

Funding

  • Anteris Technologies Corporation: $6,604.00